Search results

Page results

• UCLH researchers find way to reduce side effects of treatment for adrenal disorder

  A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.

• Having proton beam therapy: information for children aged 9-12

  Having proton beam therapy: information for children aged 9-12 patient information

• Having proton beam therapy: information for children aged 5- 8

  Having proton beam therapy: information for children aged 5- 8 patient information leaflet

• History making decision announced for Thalassaemia patients!

  Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over. 

• New UCLH clinic opens to provide COVID-19 treatments for highest risk non-hospitalised patients

  University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.

• New national study on long-term health impacts of COVID-19 launched

  UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.

• Lower Gastrointestinal suspected cancer pathway

  This page is for patients who have been referred on a suspected cancer pathway.

• Increase in delirium, rare brain inflammation and stroke linked to COVID-19

  Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.

• Cystic fibrosis drug tested to fight inflammation in COVID-19

  Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

• Information for carers of children or young people having mIBG treatment

  This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.